Fragment‐Based Drug Discovery. Edited by Steven Howard and Chris Abell

E-ISSN： 1860-7187|10|12|2112-2113

ISSN： 1860-7179

Source： CHEMMEDCHEM, Vol.10, Iss.12, 2015-12, pp. : 2112-2113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fragment-Based Drug Design: Computational and Experimental State of the Art

Combinatorial Chemistry & High Throughput Screening, Vol. 14, Iss. 6, 2011-07 ,pp. : 500-520

Bentham Science Publishers

Access to resources Recommend Favorite

Fragment‐Based Discovery of a Dual pan‐RET/VEGFR2 Kinase Inhibitor Optimized for Single‐Agent Polypharmacology

ANGEWANDTE CHEMIE, Vol. 127, Iss. 30, 2015-07 ,pp. : 8841-8845

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fragment‐Based Discovery of a Dual pan‐RET/VEGFR2 Kinase Inhibitor Optimized for Single‐Agent Polypharmacology

ANGEWANDTE CHEMIE INTERNATIONAL EDITION, Vol. 54, Iss. 30, 2015-07 ,pp. : 8717-8721

John Wiley & Sons Inc

Access to resources Recommend Favorite

Innenrücktitelbild: Fragment‐Based Discovery of a Dual pan‐RET/VEGFR2 Kinase Inhibitor Optimized for Single‐Agent Polypharmacology (Angew. Chem. 30/2015)

ANGEWANDTE CHEMIE, Vol. 127, Iss. 30, 2015-07 ,pp. : 8973-8973

John Wiley & Sons Inc

Access to resources Recommend Favorite

Macrocycles in Drug Discovery. Edited by Jeremy I. Levin

CHEMMEDCHEM, Vol. 10, Iss. 3, 2015-03 ,pp. : 580-581

John Wiley & Sons Inc

Access to resources Recommend Favorite